Comparison of the influence on renal function between cefepime and cefpirome

Jiang,Mingzi; Yao,Jing; Zhang,Li; Gao,Tianming; Zhang,Yang; Weng,Xiaoqing; Feng,Ganzhu

doi:10.3892/br.2015.528

January-2016 Volume 4 Issue 1

Full Size Image

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

An International Open Access Journal Devoted to General Medicine.

January-2016 Volume 4 Issue 1

Full Size Image

Article

Comparison of the influence on renal function between cefepime and cefpirome

Authors:
- Mingzi Jiang
- Jing Yao
- Li Zhang
- Tianming Gao
- Yang Zhang
- Xiaoqing Weng
- Ganzhu Feng
View Affiliations / Copyright

Affiliations: Department of Respiratory Medicine, The First People's Hospital of Kunshan City, Affiliated to Jiangsu University, Kunshan, Jiangsu 215300, P.R. China, Department of Respiratory Medicine, The Second Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 210000, P.R. China, Department of Pharmacy, The Second Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 210000, P.R. China
Pages: 40-44
|
Published online on: October 6, 2015

https://doi.org/10.3892/br.2015.528
Expand metrics +

Abstract

Although known for their broad spectrum and curative efficacy on drug-resistant pathogens and as nephrotoxicity-free, impairments were observed on renal function during clinical treatment of the two most commonly used fourth-generation cephalosporins: Cefpirome and cefepime. The present study aimed to further explore the exact influences of them on renal function. In vitro, the cell viability of renal cells cultured in drug‑combined medium was tested for six dilutions. In vivo, a clinical cohort study was carried out to detect the influence of cefpirome and cefepime on the serum creatinine (SCr) level of patients. Cefpirome had an inhibition rate with half maximal inhibitory concentration (IC50) of 143.5 µmol/l on renal mesangial cells, which was greater compared to the IC50 of 7.702 µmol/l for cefepime. The clinical cohort study data revealed that cefpirome treatment could lead to a greater increase of the average SCr level compared to cefepime on days 3 and 7 during therapy, and in addition, a greater incidence of SCr >445 µmol/l, an indicator of clinical renal failure. Furthermore, patients with an average age >65 years were observed as more susceptible to an SCr rise caused by either cefpirome or cefepime, with a larger augment in the average SCr, as well as a higher incidence of SCr >445 µmol/l compared to patients aged <65 years. In conclusion, cefpirome may have more potential to cause renal impairment compared to cefepime, therefore, more caution and comprehensive analysis of patient conditions is required during the clinical choice of fourth-generation cephalosporins.

View Figures

View References

1	Garau J, Wilson W, Wood M and Carlet J: Fourth-generation cephalosporins: A review of in vitro activity, pharmacokinetics, pharmacodynamics and clinical utility. Clin Microbiol Infect. 3(Suppl 1): s87–s101. 1997. View Article : Google Scholar
2	Gould IM: Do we need fourth-generation cephalosporins? Clin Microbiol Infect. 5:S1–S5. 1999. View Article : Google Scholar : PubMed/NCBI
3	Saito T, Ichinohe T, Kanda J, et al: Historical cohort study of the efficacy and safety of piperacillin/tazobactam versus fourth-generation cephalosporins for empirical treatment of febrile neutropenia in patients with hematological malignancies. Int J Clin Med. 2:18–22. 2011. View Article : Google Scholar
4	Hoffman JM, Frediani J, Herr M, Flynn PM and Adderson EE: The safety of cefepime and ceftazidime in pediatric oncology patients. Pediatr Blood Cancer. 60:806–809. 2013. View Article : Google Scholar : PubMed/NCBI
5	Gonçalves-Pereira J and Póvoa P: Antibiotics in critically ill patients: A systematic review of the pharmacokinetics of β-lactams. Crit Care. 15:R2062011. View Article : Google Scholar : PubMed/NCBI
6	Deki T, Matsuoka A, Marutani K, et al: Nephrotoxicity of cefpirome sulfate in rabbits - single and multiple intravenous administration. J Toxicol Sci. 15(Suppl 3): 173–200. 1990.(In Japanese). View Article : Google Scholar : PubMed/NCBI
7	Cojocel C: Biochemical aspects of the renal tolerance for cefpirome and other cephalosporins. Arzneimittelforschung. 40:1140–1144. 1990.PubMed/NCBI
8	Tune BM: Nephrotoxicity of β-lactam antibiotics: Mechanisms and strategies for prevention. Pediatr Nephrol. 11:768–772. 1997. View Article : Google Scholar : PubMed/NCBI
9	Rokushima M, Fujisawa K, Furukawa N, et al: Transcriptomic analysis of nephrotoxicity induced by cephaloridine, a representative cephalosporin antibiotic. Chem Res Toxicol. 21:1186–1196. 2008. View Article : Google Scholar : PubMed/NCBI
10	Soni A, Chaudhary M and Dwivedi VK: Ceftriaxone-vancomycin drug toxicity reduction by VRP 1020 in Mus musculus mice. Curr Clin Pharmacol. 4:95–101. 2009. View Article : Google Scholar : PubMed/NCBI
11	Yılmaz N, Ilhan S, Nazıroğlu M, Oktar S, Nacar A, Arıca V and Tutanç M: Ceftriaxone ameliorates cyclosporine A-induced oxidative nephrotoxicity in rat. Cell Biochem Funct. 29:102–107. 2011. View Article : Google Scholar : PubMed/NCBI

Journals

International Journal of Molecular Medicine

International Journal of Oncology

Molecular Medicine Reports

Oncology Reports

Experimental and Therapeutic Medicine

Oncology Letters

Biomedical Reports

Molecular and Clinical Oncology

World Academy of Sciences Journal

International Journal of Functional Nutrition

International Journal of Epigenetics

Medicine International

Comparison of the influence on renal function between cefepime and cefpirome

This article is mentioned in:

Abstract

Figure 1

Figure 2

Related Articles